Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
SHARON: Study of Metastatic Cancers in Patients Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives
The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic…
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
Estimated
~$10 – $8,750
General Oncology, Inc.NCT04150042
Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma
The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-10…
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
Estimated
~$10 – $8,750
Panbela Therapeutics, Inc.NCT05254171
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Aberrant miRNA production has been linked to a wide range of human cancers and shown to play important roles in their genesis and growth. These miRNA can be de…
Pancreatic Cancer Stage IIIPancreatic Cancer Stage IVPancreatic Ductal Adenocarcinoma+1 more
Estimated
~$10 – $1,125
Nuvance HealthNCT04406831
Early Detection of Pancreatic Cancer: Prospective Study
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more
Estimated
~$10 – $750
City of Hope Medical CenterNCT06388967